Posterior Urethral Valves: Multimedia

References

1. Young HH, Fronz WA, Baldwin JC. Congenital obstruction of the posterior urthera. J Urol. 1919;3:289.

2. Dewan PA, Goh DG. Variable expression of the congenital obstructive posterior urethral membrane. Urology. Mar 1995;45(3):507-9. [Medline].

3. Thomas DF, Gordon AC. Management of prenatally diagnosed uropathies. Arch Dis Child. Jan 1989;64(1 Spec No):58-63. [Medline].

4. Dinneen MD, Dhillon HK, Ward HC, Duffy PG, Ransley PG. Antenatal diagnosis of posterior urethral valves. Br J Urol. Sep 1993;72(3):364-9. [Medline].

5. Bomalaski MD, Anema JG, Coplen DE, Koo HP, Rozanski T, Bloom DA. Delayed presentation of posterior urethral valves: a not so benign condition. J Urol. Dec 1999;162(6):2130-2. [Medline].

6. Bani Hani O, Prelog K, Smith GH. A method to assess posterior urethral valve ablation. J Urol. Jul 2006;176(1):303-5. [Medline].

7. Narasimhan KL, Mahajan JK, Kaur B, Mittal BR, Bhattacharya A. The vesicoureteral reflux dysplasia syndrome in patients with posterior urethral valves. J Urol. Oct 2005;174(4 Pt 1):1433-5; discussion 1435. [Medline].

8. Atwell JD. Posterior urethral valves in the British Isles: a multicenter B.A.P.S. review. J Pediatr Surg. Feb 1983;18(1):70-4. [Medline].

9. DeFoor W, Tackett L, Minevich E, McEnery P, Kitchens D, Reeves D, et al. Successful renal transplantation in children with posterior urethral valves. J Urol. Dec 2003;170(6 Pt 1):2402-4. [Medline].

10. Gonzales ET. Posterior urethral valves and other urethral anomalies. In: Walsh PC, et al, eds. Campbell's Urology. 7^th ed. Philadelphia, Pa: W.B. Saunders; 1996:2069-91.

11. Koo HP, Bunchman TE, Flynn JT, Punch JD, Schwartz AC, Bloom DA. Renal transplantation in children with severe lower urinary tract dysfunction. J Urol. Jan 1999;161(1):240-5. [Medline].

12. Krishnan A, de Souza A, Konijeti R, Baskin LS. The anatomy and embryology of posterior urethral valves. J Urol. Apr 2006;175(4):1214-20. [Medline].

13. Parkhouse HF, Barratt TM, Dillon MJ, Duffy PG, Fay J, Ransley PG, et al. Long-term outcome of boys with posterior urethral valves. Br J Urol. Jul 1988;62(1):59-62. [Medline].

14. Reinberg Y, de Castano I, Gonzalez R. Prognosis for patients with prenatally diagnosed posterior urethral valves. J Urol. Jul 1992;148(1):125-6. [Medline].

15. Salam MA. Posterior urethral valve: Outcome of antenatal intervention. Int J Urol. Oct 2006;13(10):1317-22. [Medline].

16. Smith GH, Canning DA, Schulman SL, Snyder HM 3rd, Duckett JW. The long-term outcome of posterior urethral valves treated with primary valve ablation and observation. J Urol. May 1996;155(5):1730-4. [Medline].

17. Tejani A, Butt K, Glassberg K, Price A, Gurumurthy K. Predictors of eventual end stage renal disease in children with posterior urethral valves. J Urol. Oct 1986;136(4):857-60. [Medline].

Further Reading

Keywords

posterior urethral valves, PUVs, congenital obstructing membranes, Amussat valvula, Amussat's valvula, congenital obstructing posterior urethral membrane, COPUM, urinary tract obstruction, renal transplant, renal insufficiency, end-stage renal disease, ESRD, thickened bladder, antenatal hydronephrosis, urinary tract infection, UTI, voiding dysfunction, diurnal enuresis, proteinuria, pulmonary distress, oligohydramnios

Contributor Information and Disclosures

Author

Martin David Bomalaski, MD, FAAP, Pediatric Urologist, Alaska Southcentral Urology Specialists
Martin David Bomalaski, MD, FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, and American Urological Association
Disclosure: Nothing to disclose.

Medical Editor

Bartley G Cilento, Jr, MD, Instructor, Department of Surgery, Division of Urology, Children's Hospital of Boston and Harvard Medical School
Bartley G Cilento, Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Urological Association, and Massachusetts Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Harry P Koo, MD, Chairman of Urology Division and Director of Pediatric Urology, Virginia Commonwealth University; Professor of Surgery, VCU School of Medicine, Medical College of Virginia; Director of Urology, Children's Hospital of Richmond
Harry P Koo, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Surgeons, and American Urological Association
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Baxter Honoraria Consulting; Pfizer Honoraria Consulting

Chief Editor

Marc Cendron, MD, Associate Professor of Surgery, Harvard School of Medicine; Consulting Staff, Department of Urological Surgery, Children's Hospital Boston
Marc Cendron, MD is a member of the following medical societies: American Academy of Pediatrics, American Urological Association, European Society for Paediatric Urology, Johns Hopkins Medical and Surgical Association, New Hampshire Medical Society, Society for Fetal Urology, and Society for Pediatric Urology
Disclosure: Nothing to disclose.